Clinicopathological evaluation of duodenal well-differentiated endocrine tumors
- PMID: 20857530
- PMCID: PMC2945491
- DOI: 10.3748/wjg.v16.i36.4583
Clinicopathological evaluation of duodenal well-differentiated endocrine tumors
Abstract
Aim: To assess the clinicopathological characteristics of duodenal well-differentiated endocrine tumors.
Methods: We examined clinicopathological characteristics in 11 consecutive patients with duodenal well-differentiated endocrine tumors treated by endoscopic therapy or surgery in our hospital from 1992 through 2007. Patients with well-differentiated endocrine tumors of the papilla of Vater or with gastrinoma were excluded.
Results: Three patients received endoscopic treatment, and 8 underwent surgery. In patients who received endoscopic treatment, the tumor diameter was less than 1.0 cm, with no histopathological evidence of lymphovascular invasion or invasion of the muscularis. There were no complications such as late bleeding or perforation after treatment. Among 8 patients with tumors less than 1.0 cm in diameter, 3 underwent partial resection, and 2 underwent radical surgery. Three patients had lymphovascular invasion, 1 had invasion of the muscularis, and 1 had proximal lymph node metastasis. Among 3 patients with tumors 1.0 cm or more in diameter, 1 underwent partial resection, and 2 underwent radical surgery. One patient had lymphovascular invasion, with no lymph node metastasis. After treatment, all patients are alive and have remained free of metastasis and recurrence.
Conclusion: Duodenal well-differentiated endocrine tumors less than 1.0 cm in diameter have a risk of lymphovascular invasion, invasion of the muscularis, and lymph node metastasis, irrespective of procedural problems.
Figures



Similar articles
-
Long-term outcomes of endoscopic resection for well-differentiated nonampullary duodenal neuroendocrine tumors.Gastrointest Endosc. 2024 Sep;100(3):481-491.e6. doi: 10.1016/j.gie.2024.02.017. Epub 2024 Feb 29. Gastrointest Endosc. 2024. PMID: 38431107
-
Clinicopathological features and risk factors for lymph node metastasis in early-stage non-ampullary duodenal adenocarcinoma.J Gastroenterol. 2020 Aug;55(8):754-762. doi: 10.1007/s00535-020-01696-6. Epub 2020 Jun 12. J Gastroenterol. 2020. PMID: 32533301
-
Neuroendocrine tumours of the duodenum. Clinical aspects, pathomorphology and therapy.Langenbecks Arch Surg. 2002 Jan;386(7):525-33. doi: 10.1007/s00423-001-0260-z. Epub 2001 Nov 6. Langenbecks Arch Surg. 2002. PMID: 11819111
-
Embryologic and anatomic basis of duodenal surgery.Surg Clin North Am. 2000 Feb;80(1):171-99. doi: 10.1016/s0039-6109(05)70401-1. Surg Clin North Am. 2000. PMID: 10685148 Review.
-
AGA Institute Clinical Practice Update: Endoscopic Submucosal Dissection in the United States.Clin Gastroenterol Hepatol. 2019 Jan;17(1):16-25.e1. doi: 10.1016/j.cgh.2018.07.041. Epub 2018 Aug 2. Clin Gastroenterol Hepatol. 2019. PMID: 30077787 Review.
Cited by
-
Analysis of Prognostic Risk Factors of Endoscopic Submucosal Dissection (ESD) and Curative Resection of Gastrointestinal Neuroendocrine Neoplasms.Contrast Media Mol Imaging. 2022 Jul 8;2022:5248256. doi: 10.1155/2022/5248256. eCollection 2022. Contrast Media Mol Imaging. 2022. PMID: 35854772 Free PMC article.
-
Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature.J Gastrointest Surg. 2018 Sep;22(9):1652-1658. doi: 10.1007/s11605-018-3825-7. Epub 2018 Jun 4. J Gastrointest Surg. 2018. PMID: 29869091
-
Clinicopathologic study of neuroendocrine tumors of gastroenteropancreatic tract: a single institutional experience.J Gastrointest Oncol. 2017 Feb;8(1):139-147. doi: 10.21037/jgo.2016.12.08. J Gastrointest Oncol. 2017. PMID: 28280618 Free PMC article.
-
Clinicopathological Features of Primary Neuroendocrine Tumors of Gastrointestinal/Pancreatobiliary Tract With Emphasis on High-Grade (Grade 3) Well-Differentiated Neuroendocrine Tumors.Cureus. 2021 Jan 11;13(1):e12640. doi: 10.7759/cureus.12640. Cureus. 2021. PMID: 33585126 Free PMC article.
-
Duodenal somatostatinoma: a case report and review of the literature.J Med Case Rep. 2013 Apr 25;7:115. doi: 10.1186/1752-1947-7-115. J Med Case Rep. 2013. PMID: 23618063 Free PMC article.
References
-
- Oberndorfer S. Karzinoide tumoren des dunndarms. Frankf Z Pathol. 1907;1:426–432.
-
- DeLellis RA, Lloyd RV, Heinz PU, Eng C. WHO classification of tumors, pathology and genetics-tumors of endocrine organs. Lyon: IARC Press; 2004.
-
- Soga J. Statistical evaluation of 2001 carcinoid cases with metastases, collected from literature: a comparative study between ordinary carcinoids and atypical varieties. J Exp Clin Cancer Res. 1998;17:3–12. - PubMed
-
- Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934–959. - PubMed
-
- Soga J. Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. Cancer. 2005;103:1587–1595. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical